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1. Introduction 
Extensive research over several decades indicates a strong relationship between alcohol use 
disorders and anxiety. Stress and anxiety are implicated in both the initiation of alcohol 
consumption and the maintenance of heavy drinking (Kushner et al., 1990; Pohorecky, 
1981). For instance, anxiety disorders reliably precede the onset of alcoholism (Hettema et 
al., 2003) and over 35% of patients diagnosed with generalized anxiety disorder have 
engaged in self-medication with alcohol, defined as “drinking more than usual” in response 
to a stressor (Bolton et al., 2006). Stressors have also been linked to relapse in abstinent 
adults (Adinoff et al., 2005; Brown et al., 1995). Moreover, there is strong support suggesting 
that stress and alcohol abuse co-present so frequently as a result of common genetic factors 
in stress response systems. Genetically inherited variations in the hypothalamic-pituitary-
adrenal (HPA) axis have been implicated in vulnerability to initial alcohol abuse, sustained 
alcohol addiction, and relapse (Crabbe et al., 2006; Kreek & Koob, 1998; Shaham et al., 2003). 
This paper will discuss the putative contribution of b-endorphin to the negatively 
reinforcing effects of alcohol.  
2. The hypothalamo-pituitary-adrenocortical axis and -endorphin 
Although a thorough understanding of this nebulous concept is lacking, stress has been 
operationally defined as activation of the hypothalamo-pituitary-adrenocortical (HPA) axis 
in response to both physical and psychological stressors (for example, Pacak and Palkovits, 
2001; Uhart and Wand 2009). The stress response is coordinated by neuronal activation of 
the paraventricular nucleus in the hypothalamus leading to the release of corticotrophin-
releasing hormone (CRH) into the hypothalamic-hypophyseal portal. CRH reaches receptors 
on the anterior pituitary and initiates the synthesis of ACTH from its precursor, 
proopiomelanocortin (POMC). ACTH is released into the bloodstream where it influences 
the adrenal glands, initiating production and release of cortisol into the blood 
(corticosterone in rodents). Cortisol plays a fundamental role in the systemic reaction that 
characterizes physiological stress, though high levels of cortisol act in a negative feedback 
loop, inhibiting further CRH and ACTH synthesis in the brain.  
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Like stress, alcohol also leads to CRH release from the hypothalamus, initiating activation of 
this system (Hsu et al., 1998; see Gianoulakis, 2009; Uhart & Wand, 2009 for reviews). 
Indeed, the physiological effects of alcohol are in part mediated by the HPA axis and 
dependent upon neuronal activation of the paraventricular nucleus, and the subsequent 
release of CRH, ACTH and, eventually, adrenal activation (Lee et al., 2004). 
Related to these endocrine changes, endogenous opioids are also synthesized and released 
in response to both the experience of stress and alcohol consumption (Keith et al, 1986; 
Sarkar & Minami, 1990; Schedlowski et al, 1995; Thiagarajan, 1989). Opioids are primarily 
known for their analgesic properties, but they are highly implicated in the physiological 
rewarding effects of alcohol and other drugs of abuse (Wei & Loh, 1976; Van Ree, 1979; 
Zalewska-Kaszubska et al., 2006; see Crabbe et al., 2006 for review) as well as a wide array 
of other behavioral states. One class of endogenous opioids is the endorphins. The primary 
endorphin is β-endorphin, which is both analgesic and addictive in human and animal 
studies (Janssen & Arntz, 2011; Wie & Loh, 1976), and contributes to the rewarding and 
reinforcing properties of alcohol (Grahame 1998; Grisel et al, 1999; Williams et al, 2007). 
3. β-endorphin and alcohol 
POMC is the precursor to all endorphins, including -endorphin, which is synthesized in 
both the hypothalamus and the anterior pituitary. Endorphin producing neurons are located 
primarily in the arcuate nucleus of the hypothalamus, and project to other areas of the 
hypothalamus (supraoptic nucleus, paraventricular nucleus, and lateral hypothalamus) as 
well as to the amygdala, ventral tegmental area (VTA), periaqueductal gray, and bed 
nucleus of the stria terminalis (King & Hentges, 2011; McGinty & Bloom, 1983). Thus, β-
endorphin is well situated to influence reward, stress and pain (see Kreek & Koob, 1998 for 
review). Moreover, EtOH-initiated dopamine release in the nucleus accumbens (NAC; de 
Waele & Gianoulakis, 1993; Koob & Le Moal, 1997) is thought to involve endorphin, which 
hyperpolarizes GABAergic neurons, and thereby disinhibits dopaminergic firing in the VTA 
(Johnson & North, 1992). Thus, the effects of acute alcohol administration on β-endorphin in 
the hypothalamus (Gianoulakis, 1990; Sakar et al. 2007) contribute to the positive reinforcing 
effects of alcohol. Additionally, acute administration of alcohol initiates synthesis and 
release of β-endorphin into the bloodstream (de Waele & Gianoulakis, 1993; Keith et al., 
1986).  
The relationship between β-endorphin and alcohol suggests at least two fundamental ways 
by which this peptide may be contributing to alcoholism. The first may underlie the 
heritable liability to develop an alcohol use disorder while the second comes into play as β-
endorphin synthesis is down-regulated following chronic exposure.  
4. β-endorphin and acute alcohol exposure 
Individual variation in β-endorphin levels, as determined by heritable factors, predisposes 
individual differences in reinforcing properties of alcohol. Low β-endorphin may mediate 
enhanced reward either through more salient negative reinforcement or positive 
reinforcement from the drug. For example, the ‘opioid deficiency hypothesis’ builds on the 
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fact that individuals predisposed to alcoholism have low basal levels of -endorphin and 
suggests that alcohol administration will ameliorate this deficiency  (see Gianoulakis et al., 
2006; Herz, 1997, 1998; Zalewska-Kaszubska & Czarnecka, 2004 for reviews).  
Gianoulakis et al. (1996) examined the possibility that high risk individuals (as identified by 
familial history) will have increased sensitivity to EtOH-induced release of endogenous 
opioids, thus mediating the apparent enhanced reward those at high risk for alcoholism 
presumably experience with EtOH consumption. Subjects were between twenty and thirty 
years old and were categorized as either high risk (HR) or low risk (LR) based upon known 
family history of alcoholism. The results showed an EtOH-dose dependent increase in 
plasma β-endorphin levels in HR subjects, but not in LR subjects. This finding supports the 
notion that augmented sensitivity of β-endorphin release to EtOH could increase sensitivity 
to the positive rewards of EtOH.  
Animal studies provided further support for the idea that increased sensitivity to an EtOH-
mediated rise in β-endorphin might facilitate acquisition of alcohol drinking. We (Grisel et 
al. 1999) demonstrated that mice with low levels of β-endorphin self-administer more EtOH 
than either wild type (C57BL/6J) controls or mice that entirely lack the capacity for β-
endorphin production. In these studies we used either homozygous or heterozygous 
B6.129S2-Pomctm1Low/J mice, commercially available from Jackson Laboratories, in Bar 
Harbor, ME. The mice with low β-endorphin self-administered more EtOH and exhibited 
higher alcohol preference than controls, regardless of EtOH dose, while those without any 
capacity to synthesize the peptide consistently drank the least. This experiment suggests 
two hypotheses. One is that those with low levels of β-endorphin are more inclined to drink. 
The other, that β-endorphin contributes to the rewarding effects of EtOH. 
In animals, pharmaceutical agents that increase plasma β-endorphin levels have been most 
effective in attenuating self-administration of EtOH. Treatment of Warsaw High and Low 
Alcohol Preferring rats with the opioid antagonist naltrexone, stopped the plasma β-
endorphin increase after EtOH administration in low-preference rats, and normalized β-
endorphin plasma levels in high-preferring rats so that before and after alcohol exposure 
plasma levels were similar. These results indicate the clinical effectiveness of naltrexone in 
treatment of alcoholism may in part be due to both normalization of plasma β-endorphin 
levels and an attenuation of alcohol-rewarding properties (Zalewska-Kaszubska et al., 2006). 
In the same strains of rats, β-endorphin levels and EtOH intake were examined following 
treatment with acamprosate, which is approved for relapse prevention in withdrawing 
alcoholics. Chronic administration of acamprosate decreased voluntary intake of EtOH and 
increased plasma β-endorphin levels in high-preferring rats. Chronic administration of 
acamprosate also increased β-endorphin levels in rats in withdrawal from free EtOH access, 
suggesting that the clinical efficacy of this novel pharmacotherapy may be mediated by 
opioid effects. 
The specific influence of β-endorphin on negatively reinforcing effects of EtOH has been 
examined in animals. Negative reinforcement occurs as alcohol alleviates an aversive state 
or condition. We (Grisel et al., 2008) looked at anxious behavior as a function of basal levels 
of β-endorphin. These studies utilized the Light-Dark Box and Elevated Plus Maze to 
evaluate anxious behavior in wild-type C57BL/6J (WT), heterozygous (HT) and β-
endorphin deficient mice (B6.129S2-Pomctm1Low/J). In these assays, anxious behavior is 
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inversely related to time spent in the open or light areas of the assay apparatuses. In naïve 
subjects, the amount of time spent in the open arms of the Plus Maze or Light-Dark Box was 
inversely correlated with the amount of basal β-endorphin. These findings are consistent 
with the suggestion that β-endorphin release produces a calming and relaxing effect and 
thus lower levels of β-endorphin result in less regulation of HPA axis stress response 
(Gianoulakis, 1998; Sarkar et al., 2007). It follows that those with low basal β-endorphin 
levels, and therefore exaggerated stress responses, would be more inclined to self medicate 
with drugs of abuse, specifically anxiolytics such as EtOH (Zalewska-Kaszubska and 
Czarnecka, 2004).  
Similar experiments were also conducted following acute exposure to EtOH (Grisel et al., 
2008). Here, despite more anxious behavior at baseline, β-endorphin-deficient mice 
exhibited an exaggerated anxiolytic response after EtOH administration in both the plus 
maze and light-dark box in comparison to controls. These data may help explain the clinical 
relationship between this peptide and the propensity for alcoholism by suggesting that 
individuals with chronic β-endorphin deficiency have an increased sensitivity to the 
rewarding properties of EtOH, at least in part, because it alleviates their anxiety.  
5. Interaction between β-endorphin and sex in acute EtOH exposure 
Recent studies suggest that sex differences may play a moderating role in acute EtOH 
sensitivity differences. It is widely appreciated that females have lower incidence of 
alcoholism than males (Hunt and Zakhari, 1995), and these differences are theorized to 
manifest differences in coping response between sexes (Hettema et al., 2003). A burgeoning 
body of research supports the contention that females are more sensitive to stress than males 
(see Kleim et al., 2010; Maestripieri et al., 2010; Paris et al., 2010; Pratchett et al., 2010 for 
recent reviews of the human literature and Bangasser et al., 2010; Mogil et al., 1997; and 
Palanza 2001 for some basic research findings). For example, females, whose use and abuse 
of alcohol are increasing dramatically, also appear to be more sensitive to stress-induced 
changes in EtOH sensitivity  (see Greenfield et al., 2010; Hudson & Stamp, 2010; Przybycien-
Szymanska et al., 2010; Sartor et al., 2010).  
Sex differences in stress sensitivity appear to result, at least in part, from differences in 
hypothalamic-pituitary-adrenal (HPA) functioning mediated by an interaction between 
gonadal hormones and -endorphin (Hudson and Stamp, 2010). In β-endorphin deficient 
animals, stress response to EtOH becomes increasingly more hormone dependent (Barfield 
et al., 2010). In addition to main effects of both sex and β-endorphin on measures of stress-
induced behavior, the effect of EtOH was most profound in females deficient in endorphin. 
This triple interaction between peptide, sex and EtOH sensitivity on stress response was 
evident in females during their sexually-receptive phase, but not at other times in their 
estrous cycle.  
These data suggest a biologic mechanism for sexually-dimorphic coping responses to stress 
that is β-endorphin dependent. Unfortunately, there is a paucity of basic biomedical 
research on sex differences (Beery and Zucker, 2010) but these data suggest the need for 
future studies to examine the role the estrous cycle plays in the interaction between stress 
response and alcohol to further understand differences between males and females.  
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6. β-endorphin and chronic alcohol use 
Though genetics certainly contribute to the liability toward alcohol use disorders, excessive 
drinking in virtually anyone will lead to neural adaptations that underlie dependence, and 
β-endorphin is also implicated in those changes. The hedonic dysregulation model suggests 
that a decrease in opioid peptide function (along with other adaptations) following chronic 
alcohol consumption results in dysregulation of opioid-mediated reward transmission. This 
blunted reward circuitry is expressed phenotypically as a negative affect that exacerbates 
the potency of negative reinforcement following drug administration or adds increased 
salience to relapse related cues (Koob 2008). 
Indeed, empirical studies in humans have provided an extensive body of evidence 
supporting opioid dysregulation following chronic alcohol abuse. Chronic alcoholic patients 
exhibit decreased synthesis and release of β-endorphin as measured by plasma levels 
(Aguirre et al., 1990; see Zalewska-Kaszubska & Czarnecka, 2004 for review), and HPA axis 
dysregulation is a primary characteristic of withdrawal (Adinoff et al., 2005). Furthermore, 
the functional response of the mu-opioid receptor (which has a high affinity for β-
endorphin) is impaired after chronic exposure to EtOH (He & Whistler, 2011). It is thus 
likely that overactivity of the HPA is at least partly a result of low β-endorphin and that this 
change contributes to chronically higher basal levels of anxiety and stress during 
withdrawal (Aguirre et al., 1990; Aguirre et al., 1995 Wand, 2001).  
Investigations of recovering alcoholics have shown that levels of plasma β-endorphin are 
inversely correlated with self-rated measures of anxiety during the withdrawal period 
(Kiefer et al., 2002). Augmented negative reinforcement following alcohol consumption for 
subjects with low β-endorphin is likely because of its role in inhibiting CRH secretion. High 
levels of cortisol act as negative feedback for HPA axis stress response, (Buckingham, 1986) 
implicating β-endorphin in both behavioral allostasis and endocrine allostasis. Thus, it is 
likely that an alcohol-induced reduction of increased basal anxiety levels is a strong negative 
reinforcing factor in the maintenance of chronic alcohol dependence (Goldowitz et al., 2006; 
Kiefer et al., 2002).  
Further support for the dysregulation models comes from Aguirre et al. (1995) who 
examined the possibility of classifying individuals as alcoholics or non-alcoholics based on 
plasma β-endorphin levels. They were able to identify alcoholics and non-alcoholics over 
70% of the time by this measure alone. Even more impressively, they found a negative 
predictive value of 93.55% such that for every 100 people found to have normal plasma β-
endorphin levels, 93 would actually be non-alcoholics. The results of this study supported a 
previous finding that low β-endorphin levels are significantly more common in clinical 
cases of alcoholics (Aguirre et al., 1990). 
Plasma β-endorphin levels are involved in the withdrawal process. Kiefer et al. (2006) 
characterized alcoholics in recovery as either high preference or low preference based on 
individual average EtOH intake before detoxification. Basal β-endorphin levels of high 
preference individuals were found to be lower in comparison with low preference subjects. 
Treatment with acamprosate resulted in a significant increase in β-endorphin in high 
preference subjects but not in low preference subjects. Because acamprosate administration 
decreases withdrawal symptoms and increases abstinence, the increased β-endorphin levels 
in only high preference implicates β-endorphin deficiency as a key aspect in EtOH 
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withdrawal. In addition to acamprosate’s efficacy in treating alcoholism, it has recently been 
shown to reduce anxiety (Schwartz et al., 2010). 
7. Conclusion 
In conclusion, a growing body of research suggests that sub-optimal levels of β-endorphin 
result in compromised allostasis of the HPA axis, and that the consequent enhanced 
sensitivity to stressors facilitates high drinking. Sex differences may play a moderating role 
in the interaction between stress sensitivity, β-endorphin levels and EtOH. In general, 
individuals with deficient β-endorphin levels are likely to find EtOH more rewarding from 
both exaggerated positive and negative reinforcement. Chronic EtOH consumption leads to 
alterations in β-endorphin activity, and these changes are responsible in part for feelings of 
anxiety during withdrawal and relapse. Thus, especially in stressful situations, alcohol is 
likely to serve as an alternative coping mechanism with particular potency for those with 
labile β-endorphin and therefore predisposed to enhanced sensitivity to its anxiolytic effects.  
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